Exact Mass: 280.0946836
Exact Mass Matches: 280.0946836
Found 500 metabolites which its exact mass value is equals to given mass value 280.0946836,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Methyl nigakinone
Methyl nigakinone is a member of beta-carbolines. 4,5-Dimethoxycanthin-6-one is a natural product found in Alangium chinense, Picrasma quassioides, and Eurycoma longifolia with data available. 4,5-Dimethoxycanthin-6-one is a potent and uncompetitive inhibitor of CYP1A2-mediated phenacetin O-deethylation with an IC50 value of 1.7μM and a Ki value of 2.6 μM. 4,5-Dimethoxycanthin-6-one, as an alkaloid, is isolated from the wood of Picrasma quassioides BENNET (Simaroubaceae)[1][2]. 4,5-Dimethoxycanthin-6-one is a potent and uncompetitive inhibitor of CYP1A2-mediated phenacetin O-deethylation with an IC50 value of 1.7μM and a Ki value of 2.6 μM. 4,5-Dimethoxycanthin-6-one, as an alkaloid, is isolated from the wood of Picrasma quassioides BENNET (Simaroubaceae)[1][2].
Aspartylphenylalanine
Aspartylphenylalanine is a dipeptide composed of aspartate and phenylalanine, and is a metabolic byproduct of its methyl ester, aspartame (Nutrasweet). After hydrolysis of the ester bond in the intestinal lumen, the dipeptide is apparently absorbed and digested in the same manner as dipeptides derived from protein digestion. There are several Asp-Phe dipeptidases that degrade this peptide. It has been suggested that individuals with aspartame allergies may be deficient in this peptidase (PMID: 3743970). It has been observed that N-beta-aspartylphenylalanine (a breakdown product of Asp-Phe) is a naturally occurring peptide found in both blood and urine (PMID: 2723819).
Degradation product of Aspartame
Ipriflavone
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization Feed additive, catabolic agent. Feed additive, catabolic agent
Methoxybrassenin A
C13H16N2OS2 (280.07040059999997)
Methoxybrassenin A is found in brassicas. Methoxybrassenin A is a stress metabolite isolated from cabbage (Brassica oleracea var. capitata) inoculated with Pseudomonas cichorii. Stress metabolite isolated from cabbage (Brassica oleracea variety capitata) inoculated with Pseudomonas cichorii. Methoxybrassenin A is found in brassicas.
Gravolenic acid
Gravolenic acid is found in herbs and spices. Gravolenic acid is isolated from above-ground parts of Ruta graveolens (rue). Isolated from above-ground parts of Ruta graveolens (rue). Gravolenic acid is found in herbs and spices.
Asparenyol
Asparenyol is found in green vegetables. Asparenyol is a constituent of cultured cells of asparagus (Asparagus officinalis). Constituent of cultured cells of asparagus (Asparagus officinalis). Asparenyol is found in green vegetables.
gamma-Glutamyl-S-methylcysteine sulfoxide
gamma-Glutamyl-S-methylcysteine sulfoxide is found in onion-family vegetables. gamma-Glutamyl-S-methylcysteine sulfoxide is present in garlic (Allium sativum Present in garlic (Allium sativum). gamma-Glutamyl-S-methylcysteine sulfoxide is found in garlic, soft-necked garlic, and onion-family vegetables.
Neodunol
Neodunol is found in jicama. Neodunol is isolated from Pachyrrhizus erosus (yam bean). Isolated from Pachyrrhizus erosus (yam bean). Neodunol is found in jicama and pulses.
Phenylalanylaspartic acid
Phenylalanylaspartic acid is a dipeptide composed of phenylalanine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Methionyl-Methionine
C10H20N2O3S2 (280.09152900000004)
Methionyl-Methionine is a dipeptied compoosed of two methionine residues. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
L-beta-aspartyl-L-phenylalanine
L-beta-aspartyl-l-phenylalanine is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha Amino Acids and Derivatives. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]
Levosimendan
Levosimendan is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. It increases the sensitivity of the heart to calcium, thus increasing cardiac contractility without a rise in intracellular calcium. Levosimendan exerts its effect by increasing calcium sensitivity of myocytes by binding to cardiac troponin C in a calcium-dependent manner. It also has a vasodilatory effect, by opening adenosine triphosphate (ATP)-sensitive potassium channels in vascular smooth muscle to cause smooth muscle relaxation. D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Phenprocoumon
Phenprocoumon is only found in individuals that have used or taken this drug. It is a coumarin derivative that acts as a long acting oral anticoagulant. [PubChem]Phenprocoumon inhibits vitamin K reductase, resulting in depletion of the reduced form of vitamin K (vitamin KH2). As vitamin K is a cofactor for the carboxylation of glutamate residues on the N-terminal regions of vitamin K-dependent proteins, this limits the gamma-carboxylation and subsequent activation of the vitamin K-dependent coagulant proteins. The synthesis of vitamin K-dependent coagulation factors II, VII, IX, and X and anticoagulant proteins C and S is inhibited. Depression of three of the four vitamin K-dependent coagulation factors (factors II, VII, and X) results in decreased prothrombin levels and a decrease in the amount of thrombin generated and bound to fibrin. This reduces the thrombogenicity of clots.
3-Hydroxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
3-Hydroxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is found in fruits. 3-Hydroxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one is a constituent of the roots of Mangifera indica (mango)
N-Despyridinyl rosiglitazone
N-Despyridinyl rosiglitazone is a metabolite of rosiglitazone. Rosiglitazone is an antidiabetic drug in the thiazolidinedione class of drugs. It works as an insulin sensitizer, by binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. It is marketed by the pharmaceutical company GlaxoSmithKline (GSK) as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Annual sales peaked at approximately $2.5bn in 2006, but declined after reports of adverse effects. (Wikipedia)
4-(2-Aminopyrimidin-4-yl)-6-(2-aminopyrimidin-4(3H)-ylidene)cyclohexa-2,4-dien-1-one
Flumecinol
C26170 - Protective Agent > C2081 - Hepatoprotective Agent
N-(gamma-Maleimidobutyryloxy)succinimide
Mitoflaxone
C26170 - Protective Agent > C275 - Antioxidant > C306 - Bioflavonoid D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Simendan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Nortanshinone
Nortanshinone is a natural product found in Salvia miltiorrhiza, Salvia przewalskii, and Salvia yunnanensis with data available.
12-Bromo-4(13),6,9-lauratriene
4,5-Dimethoxycanthin-6-one
4,5-Dimethoxycanthin-6-one is a potent and uncompetitive inhibitor of CYP1A2-mediated phenacetin O-deethylation with an IC50 value of 1.7μM and a Ki value of 2.6 μM. 4,5-Dimethoxycanthin-6-one, as an alkaloid, is isolated from the wood of Picrasma quassioides BENNET (Simaroubaceae)[1][2]. 4,5-Dimethoxycanthin-6-one is a potent and uncompetitive inhibitor of CYP1A2-mediated phenacetin O-deethylation with an IC50 value of 1.7μM and a Ki value of 2.6 μM. 4,5-Dimethoxycanthin-6-one, as an alkaloid, is isolated from the wood of Picrasma quassioides BENNET (Simaroubaceae)[1][2].
Ethyl phthalyl ethyl glycolate
CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8547; ORIGINAL_PRECURSOR_SCAN_NO 8543 ORIGINAL_ACQUISITION_NO 8582; CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 8579 CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8582; ORIGINAL_PRECURSOR_SCAN_NO 8579 CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8594; ORIGINAL_PRECURSOR_SCAN_NO 8590 CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8629; ORIGINAL_PRECURSOR_SCAN_NO 8624 CONFIDENCE standard compound; INTERNAL_ID 554; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8644; ORIGINAL_PRECURSOR_SCAN_NO 8639
N-benzyl-5-methoxy-1H-indole-2-carboxamide
C17H16N2O2 (280.12117159999997)
6-O-malonyl-beta-methyl-D-glucopyranoside|6-O-malonyl-??-methyl-D-glucopyranoside|methyl 6-O-(2-carboxyacetyl)-beta-D-glucopyranoside
Methylenedihydrotanshinquinone
6-acetoxy-8,9-dehydro-6-carbomethoxy-10-hydroxy-thymol
(3R*,4R*)-3,4-dihydro-3,4,8-trihydroxy-6-methoxy-3-(2-oxopropyl)naphthalen-1(2H)-one|balticol D
2-Hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene|8-carboxy-2-hydroxy-1-methyl-5-vinyl-9,10-dihydrophenanthrene|9,10-Dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid
7-(phenyl-methylcarbonyl)oxy-2H-1-benzopyran-2-one|7-phenylacetoxycoumarin
2-(2-methoxy-4-hydroxyphenyl)-5-(E)-propenylbenzofuran|Ratanhiaphenol III
(5Z)-5-(4-hydroxybenzylidene)-4-(4-hydroxyphenyl)furan-2(5H)-one|4-(4-hydroxyphenyl)-5-[(Z)-(4-hydroxyphenyl)methylidene]furan-2-one|Rubrolide E
(E)-2,3-dihydroxycyclopentyl-3-(3,4-dihydroxyphenyl)acrylate|1-(3,4-dihydroxycinnamoyl)cyclopentane-2,3-diol
2,7-dimethoxy-5H-phenanthro[4,5-bcd]pyran-5-one|uniflorinanthrone
3-(methoxycarbonyl)propyl beta-D-glucopyranoside|3-(Methoxycarbonyl)propyl-??-D-glucopyranoside
4-(9h-beta-carbolin-1-yl)-4-oxobut-2-enoic acid methyl ester
(4bR,10bR)-4b-hydroxy-10b,12-dihydrodibenzo[c,h][2,6]naphthyridine-5,11(4bH,6H)-dione
(6S,8S)-5,6,7,8-tetrahydro-1,3,6-trihydroxy-6-acetyl-8-methylnaphthalene-4-carboxylic acid|ficuselastic acid
(Z)-4,4-dihydroxy-3-methoxy-1,5-diphenylpent-3-en-1-yne|lawsochylin C
2-(1,3-benzodioxol-5-yl)ethyl 5-hydroxy-4-oxo-pentanoate
6-(1-bromo-2-methyl-propyl)-1,4-dimethyl-5,6-dihydro-4H-indene
(E)-2-(4-hydroxyphenyl)-7-methoxy-5-(1-propenyl)benzofuran|2-(4-hydroxyphenyl)-7-methoxy-5-(E)-propenylbenzofuran|7-Metoxy-2-(4-Hydroxyphenyl)-5-(1-propenyl)-benzofuran
2-(2-hydroxy-4-methoxyphenyl)-5-(E)-propenylbenzofuran|Ratanhiaphenol I|rataniaphenol III|ratanthiaphenol
(4-hydroxyphenyl)-[5-(4-hydroxyphenyl)-1H-imidazol-2-yl]methanone
1-Methyl-3-phenethyl-1,2,3,4-tetrahydroquinazoline-2,4-dione
C17H16N2O2 (280.12117159999997)
2-(4-hydroxyphenyl)-5-(2-oxopropyl)-3-methylbenzofuran
(E)-1-(L-cystein-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine
C10H20N2O3S2 (280.09152900000004)
N-(9H-Purin-6-ylcarbamoyl)threonine
C10H12N6O4 (280.09199920000003)
Zhebeiresinol
Zhepeiresinol is a natural product found in Magnolia kachirachirai, Ilex pubescens, and Callicarpa pilosissima with data available.
ipriflavone
M - Musculo-skeletal system > M05 - Drugs for treatment of bone diseases > M05B - Drugs affecting bone structure and mineralization relative retention time with respect to 9-anthracene Carboxylic Acid is 1.328 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.329
Levosimendan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
C17H16N2O2_1H-1,4-Benzodiazepine-2,5-dione, 3,4-dihydro-4-methyl-3-(phenylmethyl)
C17H16N2O2 (280.12117159999997)
Asp-phe
A dipeptide formed from L-alpha-aspartyl and L-phenylalanine residues. It is obtained after the hydrolysis of aspartame in intestinal lumen.
Phenprocoumon
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AA - Vitamin k antagonists A hydroxycoumarin that is 4-hydroxycoumarin which is substituted at position 3 by a 1-phenylpropyl group. D006401 - Hematologic Agents > D000925 - Anticoagulants > D015110 - 4-Hydroxycoumarins C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
6-hydroxy-7E,9E-Octadecadiene-11,13,15,17-tetraynoic acid
6-hydroxy-7E,9Z-Octadecadiene-11,13,15,17-tetraynoic acid
6-hydroxy-7Z,9E-Octadecadiene-11,13,15,17-tetraynoic acid
Levosimedan
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058987 - Phosphodiesterase 3 Inhibitors C - Cardiovascular system > C01 - Cardiac therapy > C01C - Cardiac stimulants excl. cardiac glycosides C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D020011 - Protective Agents > D002316 - Cardiotonic Agents
Met-met
C10H20N2O3S2 (280.09152900000004)
A dipeptide formed from two L-methionine residues.
Phe-asp
A dipeptide formed from L-phenylalanine and L-aspartic acid residues.
g-Glutamyl-S-methylcysteine sulfoxide
Gravolenic acid
Methoxybrassenin A
C13H16N2OS2 (280.07040059999997)
3-(2-AMINOETHYLSULFANYL)-1-(4-METHOXY-PHENYL)PYRROLIDINE-2,5-DIONE
3-BENZYL-IMIDAZO[1,5-A]PYRIDINE-1-CARBOXYLIC ACID ETHYL ESTER
C17H16N2O2 (280.12117159999997)
(2S,4S)-4-Boc-Amino pyrrolidine-2-carboxylic acid methylester hydrochloride
2-AMINO-4-METHOXY-7-(BETA-D-2-DEOXYRIBOFURANOSYL)PYRROLO[2,3-D]PYRIMIDINE
(R)-4-N-BOC-PIPERAZINE-2-CARBOXYLIC ACID METHYL ESTER-HCl
3-{[3-(TRIFLUOROMETHYL)BENZYL]OXY}BENZALDEHYDE
C15H11F3O2 (280.07111019999996)
4-{[3-(TRIFLUOROMETHYL)BENZYL]OXY}BENZALDEHYDE
C15H11F3O2 (280.07111019999996)
tert-Butyl 6-(aminomethyl)thieno[2,3-d]pyrimidin-4-ylcarbamate
[3-(Trifluoromethyl)-4-biphenylyl]acetic acid
C15H11F3O2 (280.07111019999996)
3-AMINO-2,7-DIMETHYL-5,6,7,8-TETRAHYDRO-[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE
3-BENZYL-4-OXO-3,4-DIHYDRO-PHTHALAZINE-1-CARBOXYLIC ACID
6-BROMO-1,1,4,4,7-PENTAMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENE
2,4-Imidazolidinedione,5,5-bis(phenylmethyl)-
C17H16N2O2 (280.12117159999997)
3-METHYL-5-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
C15H11F3O2 (280.07111019999996)
2-{[3-(TRIFLUOROMETHYL)BENZYL]OXY}BENZALDEHYDE
C15H11F3O2 (280.07111019999996)
5-METHYL-2-NAPHTHALEN-1-YL-3H-IMIDAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
C17H16N2O2 (280.12117159999997)
3-(4-METHOXYPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHANOL
C17H16N2O2 (280.12117159999997)
Ethyl 3-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl) propanoate
4-(2-METHYL-4-OXO-4 H-QUINAZOLIN-3-YL)-BENZOIC ACID
bis(trimethylsilyl)hypoxathine
9-(Trimethylsilyl)-6-[(trimethylsilyl)oxy]-9H-purine. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=17962-89-9 (retrieved 2024-09-24) (CAS RN: 17962-89-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
1-Phenyl-3-[(phenylmethyl)amino]-2,5-pyrrolidinedione
C17H16N2O2 (280.12117159999997)
3-(3,5-Dimethyl-1H-pyrazol-4-ylmethyl)-4-methoxy-benzaldehyde hydrochloride
METHYL (2R,4S)-4-BOC-AMINOPYRROLIDINE-2-CARBOXYLATE HYDROCHLORIDE
1-(4-aminobenzoyl)-3,4-dihydro-2H-1-benzazepin-5-one
C17H16N2O2 (280.12117159999997)
Ethyl 6-amino-2-phenyl-1H-indole-3-carboxylate
C17H16N2O2 (280.12117159999997)
4-(2,6-Dimethylmorpholin-4-yl)-3-nitrobenzoic acid
(S)-1-tert-Butyl 2-methyl piperazine-1,2-dicarboxylate hydrochloride
N-[(2,4-DIPHENYL-1,3-THIAZOL-5-YL)METHYL]-N-METHYLAMINE
7H-spiro[furo[3,4-b]pyridine-5,4-piperidin]-7-onedihydrochloride
N-Boc-cis-4-Amino-L-proline methyl ester hydrochloride
2-(3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-YL)ACETIC ACID
C15H11F3O2 (280.07111019999996)
METHYL 4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-4-CARBOXYLATE
C15H11F3O2 (280.07111019999996)
1-amino-4-[(1-methylethyl)amino]anthraquinone
C17H16N2O2 (280.12117159999997)
methyl 2-[4-(trifluoromethyl)phenyl]benzoate
C15H11F3O2 (280.07111019999996)
N-Boc-trans-4-amino-L-proline methyl ester hydrochloride
2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid hydrochloride
2-(4-BENZYLOXY-PHENYL)-OXAZOL-4-YL-METHYLAMINE
C17H16N2O2 (280.12117159999997)
(E)-3-Cyclopentyl-2-(4-(methylsulfonyl)phenyl)prop-2-en-1-ol
METHYL 4-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLATE
C15H11F3O2 (280.07111019999996)
3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4-methyl-1,3-thiazol-2-one
Ethyl 1-benzyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
C17H16N2O2 (280.12117159999997)
1H-PYRROLO[2,3-B]PYRIDINE, 1-(METHYLSULFONYL)-4-(1-PIPERAZINYL)-
4-OXO-3-PHENYL-3,4-DIHYDROPHTHALAZINE-1-CARBOHYDRAZIDE
1,3-Piperazinedicarboxylic acid, 1-(1,1-dimethylethyl) 3-methyl ester, hydrochloride (1:1), (3S)-
1H-Indole-3-acetamide,5-(phenylmethoxy)-
C17H16N2O2 (280.12117159999997)
(2r,3r)-2,3-o-(1-phenylethylidene)-l-tartaric acid dimethyl ester
6-[5-(4-methoxyphenyl)-1,2-dihydropyrazol-3-ylidene]-4-methylcyclohexa-2,4-dien-1-one
C17H16N2O2 (280.12117159999997)
6-(BROMOMETHYL)-1,1,4,4-TETRAMETHYL-1,2,3,4-TETRAHYDRONAPHTHALENE
3-((4-Oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
6(5H)-Pteridinone, 2-chloro-8-cyclopentyl-7-ethyl-7,8-dihydro
(S)-(6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methanamine dihydrochloride
Pyridin-4-yl-glycine tert-butyl ester dihydrochloride
N-(6-Ethoxy-2,3-dihydro-1,3-benzothiazol-2-yl)-3-oxobutanamide
(4,5-DIMETHYL-3-PHENYL-3H-THIAZOL-2-YLIDENE)-PHENYL-AMINE
(3-(Morpholine-4-carbonyl)-5-nitrophenyl)boronic acid
(2-CHLORO-4-MORPHOLINOPYRIDO[2,3-D]PYRIMIDIN-7-YL)METHANOL
(2R,4R)-Methyl 4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylate hydrochloride
6-Methyl-2-(4-methylphenyl)imidazo[1,2-a]-pyridine-3-acetic acid
C17H16N2O2 (280.12117159999997)
Ethyl 8-chloro-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate
(2S,4R)-4-BOC-AMINO PYRROLIDINE-2-CARBOXYLIC ACID METHYLESTER-HCL
2-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxycarbonyl]benzoic acid
Imiloxan hydrochloride
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist
5-[4-(2-Methylaminoethoxy)-benzyl]-thiazolidine-2,4-dione
Rataniaphenol I
A member of the class of benzofurans that is 1-benzofuran substituted by a 2-hydroxy-4-methoxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
N-[2-(6-Chloro-5-methoxy-2-methyl-1H-indol-3-YL)ethyl]acetamide
2-oxo-N-(2-pyridinylmethyl)-1-benzopyran-3-carboxamide
3-(2-Pyridinyl)-6-(2-pyridinylmethylthio)pyridazine
4H-1-Benzopyran-4-one, 6-methoxy-2-(2-phenylethyl)-
4H-1-Benzopyran-4-one, 2-(2-methoxyphenyl)-6,8-dimethyl-
1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide
C9H16N2O8 (280.09066160000003)
(1S)-1,2,3,4-Tetrahydro-benzo[C]phenanthrene-2,3,4-triol
2-[(2-Amino-3-phenylpropanoyl)amino]butanedioic acid
isopropyl 6-O-acetyl-beta-D-thiogalactopyranoside
C11H20O6S (280.09805400000005)
2-(1H-indol-3-ylamino)-3-phenylpropanoic acid
C17H16N2O2 (280.12117159999997)
(2R)-2-amino-3-[(E)-N-hydroxy-C-(5-methylsulfanylpentyl)carbonimidoyl]sulfanylpropanoic acid
C10H20N2O3S2 (280.09152900000004)
(2S,3R,4S)-2-amino-3,5-dihydroxy-4-(hydroxymethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
(2S,3R,4R)-2-amino-3,5-dihydroxy-4-(hydroxymethyl)-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
4-(4-hydroxy-3,5-dimethylphenyl)-2-methylphthalazin-1(2H)-one
C17H16N2O2 (280.12117159999997)
Rataniaphenol III
A member of the class of benzofurans that is 1-benzofuran substituted by a 2-methoxy-4-hydroxyphenyl group at position 2 and a prop-1-en-1-yl group at position 5. It is a lignan derivative isolated from the roots of Krameria lappacea.
4-(2-hydroxyphenyl)-8,9-dimethyl-2,3-dihydro-1H-1,5-benzodiazepin-2-one
C17H16N2O2 (280.12117159999997)
3-Benzyl-5-tert-butyl-1,3,5-thiadiazinane-2-thione
3-[(4-methoxyanilino)methyl]-1H-quinolin-2-one
C17H16N2O2 (280.12117159999997)
N-(4-tert-butyl-2-thiazolyl)-5-methyl-2-thiophenecarboxamide
C13H16N2OS2 (280.07040059999997)
2,4-difluoro-N-[[(5-methyl-1H-pyrazol-3-yl)amino]-oxomethyl]benzamide
4-{(E)-[2-(1H-benzimidazol-2-yl)hydrazinylidene]methyl}benzoic acid
(1S,3S,11R,11aR)-3-amino-1,7,8,11-tetrahydroxy-1,2,3,6,11,11a-hexahydro-4H-pyrido[1,2-b]isoquinolin-4-one
3-(4-Methoxyphenyl)-5-(2-phenylethyl)-1,2,4-oxadiazole
C17H16N2O2 (280.12117159999997)
N-[(E)-furan-2-ylmethylideneamino]-3-phenyl-1H-pyrazole-5-carboxamide
4-[(3,5-Dimethylphenyl)-oxomethyl]-1,3-dihydroquinoxalin-2-one
C17H16N2O2 (280.12117159999997)
2-{2-[5-(2-Hydroxyphenyl)-1,2,4-oxadiazol-3-yl]vinyl}phenol
2-oxo-N-(3-pyridinylmethyl)-1-benzopyran-3-carboxamide
N-[2-[2,3-dihydroindol-1-yl(oxo)methyl]phenyl]acetamide
C17H16N2O2 (280.12117159999997)
2-(3-imino-1H-isoindol-2-yl)-1-(4-methoxyphenyl)ethanone
C17H16N2O2 (280.12117159999997)
3,7-Dimethyl-2-(methylthio)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-one
C13H16N2OS2 (280.07040059999997)
(3Z)-3-{[(6-methylpyridin-2-yl)amino]methylidene}-2H-chromene-2,4(3H)-dione
3-[(2-pyridinylmethylamino)methylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione
3-(4,7-Dimethyl-1-quinolin-1-iumyl)-1-propanesulfonic acid
3-(2,7-Dimethyl-1-quinolin-1-iumyl)-1-propanesulfonic acid
(Z)-2-cyano-3-(3,4-dihydroxyphenyl)-N-phenylprop-2-enamide
6-(1-Carboxypropan-2-yloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
(5Z)-3-butyl-5-(1-methylpyridin-2-ylidene)-2-sulfanylidene-1,3-thiazolidin-4-one
C13H16N2OS2 (280.07040059999997)
6-(2-Carboxypropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
1-Methyl 3-(3,4,5,6-tetrahydroxyoxan-2-yl)methyl propanedioate
(5Z)-5-(dimethylaminomethylidene)-3-(4-methylphenyl)-1,1-dioxo-1,3-thiazolidin-4-one
6-(2-Carboxypropan-2-yloxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
6-(1-Carboxypropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
[(4R)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]methyl octanoate
C11H21O6P (280.10756960000003)
(3S)-3-benzyl-4-methyl-3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione
C17H16N2O2 (280.12117159999997)
3-Hydroxy-2-(4-methylbenzoyl)-4H-1-benzopyran-4-one
2-Isopropyl-3-(4-hydroxybenzoyl)benzofuran
2-(2-(4-methoxyphenyl)ethyl)chromone
A member of the class of chromones that is chromone which is substituted by a 2-(4-methoxyphenyl)ethyl group at position 2. It is found in agarwood, a fragrant resinous heartwood from trees of the genus Aquilaria.
fumisoquin A
A pyridoisoquinoline that is (11aR)-1,3,4,6,11,11a-hexahydro-2H-pyrido[1,2-b]isoquinoline substituted by hydoxy groups at positions 1S,7,8 and 11R, by an amino group at position 3S and an oxo group at position 4. It is produced by a biosynthetic gene cluster called fsq in the human pathogen Aspergillus fumigatus.
MK-0608
MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay[1].
N-Salicyloyltryptamine
C17H16N2O2 (280.12117159999997)
N-Salicyloyltryptamine acts on voltage-dependent Na+, Ca2+, and K+ ion channels inhibitor. N-Salicyloyltryptamine inhibits K+ currents with an IC50 value of 34.6 μM (Ito). N-Salicyloyltryptamine also exhibits anticonvulsant, anti-inflammatory, analgesic, and vasorelaxation effect[1]-[5].
(3s)-4-[(1r,2r)-1,5-dihydroxy-4-oxo-2,3-dihydro-1h-naphthalen-2-yl]-3-hydroxybutanoic acid
(3as,4s,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
5-methoxy-2-[5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenol
methyl 3-(7-hydroxy-8-methoxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)propanoate
(2r,3r,4s,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(4s,6s)-6,9,11-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxecine-2,8-dione
1-[(1s,3r)-3-bromo-1,2,2-trimethylcyclopentyl]-4-methylbenzene
4-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylidene]furan-2-one
4-ethenyl-7-hydroxy-8-methyl-9,10-dihydrophenanthrene-1-carboxylic acid
(1r,2s,5r)-5-[(8r)-8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl]-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol
3,11-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
(2s)-2-({4-[(1-hydroxyethylidene)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)-3-methylbutanoic acid
6-chloro-5-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2,2,7-trimethyl-3h-inden-1-one
3-(2,3-dihydroxypropyl)-6,8-dimethoxychromen-2-one
1-methyl-3-(2-phenylethyl)quinazoline-2,4-dione
C17H16N2O2 (280.12117159999997)
[(3r,4r)-4,8-dihydroxy-3,4-dimethyl-1-oxo-3h-2-benzopyran-7-yl]methyl acetate
(3s,5s)-5-[(2s,3s,4r)-2-chloro-1,3,4-trihydroxyheptyl]-3-methyloxolan-2-one
3-amino-1,7,8,11-tetrahydroxy-1h,2h,3h,6h,11h,11ah-pyrido[1,2-b]isoquinolin-4-one
1,2,15,16-tetrahydrotanshinone i
{"Ingredient_id": "HBIN000539","Ingredient_name": "1,2,15,16-tetrahydrotanshinone i","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCC=C4C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21064","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-3-methylbutanoic acid,9ci; (r)-form,o-(3,4-methylenedioxybenzoyl),me ester
{"Ingredient_id": "HBIN005747","Ingredient_name": "2-hydroxy-3-methylbutanoic acid,9ci; (r)-form,o-(3,4-methylenedioxybenzoyl),me ester","Alias": "NA","Ingredient_formula": "C14H16O6","Ingredient_Smile": "NA","Ingredient_weight": "280.27","OB_score": "NA","CAS_id": "126518-78-3","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8618","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-7-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene
{"Ingredient_id": "HBIN005771","Ingredient_name": "2-hydroxy-7-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1=C(C=CC2=C1CCC3=CC(=CC(=C32)C=C)C(=O)O)O","Ingredient_weight": "280.34","OB_score": "24.82961582","CAS_id": "NA","SymMap_id": "SMIT00724","TCMID_id": "9892","TCMSP_id": "MOL007919","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene
{"Ingredient_id": "HBIN005773","Ingredient_name": "2-hydroxy-8-carboxy-1-methyl-5-ethenyl-9,10-dihydrophenanthrene","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "CC1=C(C=CC2=C1CCC3=C(C=CC(=C32)C=C)C(=O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15817","TCMID_id": "9893","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3-(methoxycarbonyl)propyl-β-d-glucopyra-noside
{"Ingredient_id": "HBIN008821","Ingredient_name": "3-(methoxycarbonyl)propyl-\u03b2-d-glucopyra-noside","Alias": "NA","Ingredient_formula": "C11H20O8","Ingredient_Smile": "COC(=O)CCCOC1C(C(C(C(O1)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13870","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid
{"Ingredient_id": "HBIN013941","Ingredient_name": "9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-1-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "NA","Ingredient_weight": "280.32","OB_score": "NA","CAS_id": "147850-85-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7301","PubChem_id": "NA","DrugBank_id": "NA"}
9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-2-phenanthrenecarboxylic acid
{"Ingredient_id": "HBIN013942","Ingredient_name": "9,10-dihydro-7-hydroxy-8-methyl-4-vinyl-2-phenanthrenecarboxylic acid","Alias": "NA","Ingredient_formula": "C18H16O3","Ingredient_Smile": "NA","Ingredient_weight": "280.32","OB_score": "NA","CAS_id": "144106-82-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7300","PubChem_id": "NA","DrugBank_id": "NA"}
asarumin d
{"Ingredient_id": "HBIN017034","Ingredient_name": "asarumin d","Alias": "NA","Ingredient_formula": "C14H16O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1839","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1-(3-bromo-1,2,2-trimethylcyclopentyl)-4-methylbenzene
(2s)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}butanedioic acid
(2r,3r,4s,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
3-(chloromethyl)-6-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one
methyl 3-[(3r)-7-hydroxy-8-methoxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]propanoate
(2e)-3-{4-[2-hydroxy-4-(prop-2-en-1-yl)phenoxy]phenyl}prop-2-enal
3-phenylprop-2-en-1-yl 3-(4-hydroxyphenyl)prop-2-enoate
1-methyl-7h,8h,9h-phenanthro[1,2-b]furan-6,10,11-trione
4-[7-methoxy-5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenol
6,7,8-trimethoxy-3-(propan-2-ylidene)-1,4-benzodioxin-2-one
(2s)-2-[(2r)-1-(acetyloxy)-2-hydroxypropan-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid
1,6-dimethyl-1h,2h,8h,9h-phenanthro[1,2-b]furan-10,11-dione
(2e)-3-[2',6-dihydroxy-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-yl]prop-2-enal
3-methoxy-4-[5-(prop-1-en-1-yl)-1-benzofuran-2-yl]phenol
[7-hydroxy-2-(2-hydroxypropyl)-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetic acid
(3s,6s)-3-(chloromethyl)-6-hydroxy-4,7,7-trimethyl-3h,6h,8h-indeno[4,5-c]furan-1-one
6,9,11-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxecine-2,8-dione
(3ar,4s,6ar)-4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
(3s,5s)-5-(3-acetyl-2,6-dihydroxy-5-methylphenyl)-3-methoxyoxolan-2-one
(4r,6r)-6,9,11-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxecine-2,8-dione
4-ethenyl-7-hydroxy-8-methyl-9,10-dihydrophenanthrene-2-carboxylic acid
(3s,5s)-5-[(2s,3r,4r)-3-chloro-1,2,4-trihydroxyheptyl]-3-methyloxolan-2-one
3-[4',6-dihydroxy-3'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-yl]prop-2-enal
3-oxo-3-[(3,4,5-trihydroxy-6-methoxyoxan-2-yl)methoxy]propanoic acid
4,5,8-trihydroxy-6-methoxy-3-(2-oxopropyl)-3,4-dihydro-2h-naphthalen-1-one
methyl 4-(3-acetyl-2,6-dihydroxyphenyl)-2-methoxybut-3-enoate
3-[(2s,4s)-2,4-dihydroxypentyl]-6,8-dihydroxyisochromen-1-one
3-oxo-3-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methoxy}propanoic acid
3-[(2r,4r)-2,4-dihydroxypentyl]-6,8-dihydroxyisochromen-1-one
(2e)-3-phenylprop-2-en-1-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(2r,3r,4r,5r,6r)-2-[(3s)-3,4-dihydroxy-2-methylidenebutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 2h-phenanthro[3,4-d][1,3]dioxole-5-carboxylate
methyl 4-oxo-4-{9h-pyrido[3,4-b]indol-1-yl}but-2-enoate
(s)-{4-[(ethoxycarbonyl)amino]phenyl}[(1-hydroxyethylidene)amino]acetic acid
(3as,4r,6as)-4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
(2r,5s)-2,5-dihydroxycyclopentyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methyl (1r,2r,3r)-2-(2,5-dihydroxybenzoyl)-3-hydroxycyclopentane-1-carboxylate
(1s,2r,5r)-5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol
4-{7-methoxy-5-[(1e)-prop-1-en-1-yl]-1-benzofuran-2-yl}phenol
4-methoxy-6-methyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-4,7,9(16),10(15),11,13-hexaene-2,3-dione
(4r,6r)-6-[(1r)-1-bromo-2-methylpropyl]-1,4-dimethyl-5,6-dihydro-4h-indene
(3as,6s,6ar,9ar,9br)-8-chloro-6,9a-dimethyl-3-methylidene-3ah,4h,5h,6h,6ah,9bh-azuleno[4,5-b]furan-2,9-dione
2-(3,4-dimethylphenyl)-5-hydroxy-7-methylchromen-4-one
3-(2,4-dihydroxypentyl)-6,8-dihydroxyisochromen-1-one
13-methoxy-6-methyl-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-4,7,9(16),10(15),11,13-hexaene-2,3-dione
12,13-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
(2e,4e)-5-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methylidene]pent-4-enal
(1r,2r,4s,6r)-9-chloro-1,4-dimethyl-11-methylidene-10-oxotricyclo[6.3.0.0²,⁶]undec-8-ene-4-carboxylic acid
2-({4-[(1-hydroxyethylidene)amino]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)-3-methylbutanoic acid
3-(1,2-dihydroxypropyl)-6,8-dimethoxychromen-2-one
3-(hydroxymethyl)-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
1-[(1s,3s)-3-bromo-1,2,2-trimethylcyclopentyl]-4-methylbenzene
(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl 3-phenylprop-2-enoate
1-[3-(bromomethyl)-1-methyl-2-methylidenecyclopentyl]-4-methylcyclohexa-1,4-diene
5-[5-(hydroxymethyl)-4-methoxy-6-oxopyran-2-yl]-3-methylhexa-2,4-dienoic acid
8,17-diazatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-2,4,6,8,11,13,15,17-octaene-1,9,18-triol
(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl (2e)-3-phenylprop-2-enoate
2-(hydroxymethyl)-6-(thian-3-yloxy)oxane-3,4,5-triol
C11H20O6S (280.09805400000005)
(1s,2'r,3's,5's)-2',3',4-trihydroxy-6-methoxy-5'-methylspiro[2-benzofuran-1,1'-cyclopentan]-3-one
(2r,3r,4r,5s,6r)-2-(3,4-dihydroxy-2-methylidenebutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(7e,9z)-6-hydroxyoctadeca-7,9-dien-11,13,15,17-tetraynoic acid
(1r,2r,3r)-2,3-dihydroxycyclopentyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2e)-3-[4',6-dihydroxy-3'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-yl]prop-2-enal
(1r,10r)-8,17-diazatetracyclo[8.8.0.0²,⁷.0¹¹,¹⁶]octadeca-2,4,6,8,11,13,15,17-octaene-1,9,18-triol
1-hydroxy-2-isopropyl-8-methylphenanthrene-3,4-dione
3,13-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-3,5,7,9(16),10(15),11,13-heptaen-2-one
4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
methyl 3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate
methyl (3s)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoate
3-[2',6-dihydroxy-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-3-yl]prop-2-enal
4-(3-methylbut-2-en-1-yl)phenazine-1,6-diol
C17H16N2O2 (280.12117159999997)
(2r,3r,4s,6s)-3,4,10-trihydroxy-12-methoxy-6-methyl-7-oxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-8-one
methyl 2-(2,5-dihydroxybenzoyl)-3-hydroxycyclopentane-1-carboxylate
(4,8-dihydroxy-3,4-dimethyl-1-oxo-3h-2-benzopyran-7-yl)methyl acetate
[(2s)-7-hydroxy-2-[(2s)-2-hydroxypropyl]-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetic acid
methyl (2e)-4-oxo-4-{9h-pyrido[3,4-b]indol-1-yl}but-2-enoate
1-[(1s,3s)-3-(bromomethyl)-1-methyl-2-methylidenecyclopentyl]-4-methylcyclohexa-1,4-diene
methyl (2z)-3-[5-(acetyloxy)-2-hydroxy-4-methylphenyl]-4-hydroxybut-2-enoate
(3s,5r)-5-(3-acetyl-2,6-dihydroxy-5-methylphenyl)-3-methoxyoxolan-2-one
1-[2-(4-hydroxyphenyl)-3-methyl-1-benzofuran-5-yl]propan-2-one
5-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methylidene]pent-4-enal
methyl 3-[5-(acetyloxy)-2-hydroxy-4-methylphenyl]-4-hydroxybut-2-enoate
(5z)-4-(4-hydroxyphenyl)-5-[(4-hydroxyphenyl)methylidene]furan-2-one
5-(3-acetyl-2,6-dihydroxy-5-methylphenyl)-3-methoxyoxolan-2-one
(4r,6s)-6,9,11-trihydroxy-4-methyl-4,5,6,7-tetrahydro-1h-3-benzoxecine-2,8-dione
3,4,10-trihydroxy-12-methoxy-6-methyl-7-oxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-8-one
6-(1-bromo-2-methylpropyl)-1,4-dimethyl-5,6-dihydro-4h-indene
2,3-dihydroxycyclopentyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
5-{8-hydroxy-4h,7h,8h-imidazo[4,5-d][1,3]diazepin-3-yl}-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol
(3s,4s)-4,5,8-trihydroxy-6-methoxy-3-(2-oxopropyl)-3,4-dihydro-2h-naphthalen-1-one
(7z,9e)-6-hydroxyoctadeca-7,9-dien-11,13,15,17-tetraynoic acid
(3ar,4s,6ar)-4-(3-hydroxy-4,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
{4-[(ethoxycarbonyl)amino]phenyl}[(1-hydroxyethylidene)amino]acetic acid
(2e,4e)-5-[(2s,3s)-5-(2-carboxyethyl)-3-methyl-6-oxo-2,3-dihydropyran-2-yl]penta-2,4-dienoic acid
[(2r)-7-hydroxy-2-[(2s)-2-hydroxypropyl]-4-oxo-2,3-dihydro-1-benzopyran-5-yl]acetic acid
10-methoxy-2-methyl-6h,7h,12h-indolo[2,3-a]quinolizin-4-one
C17H16N2O2 (280.12117159999997)
(3ar,4r,6ar)-4-(4-hydroxy-3,5-dimethoxyphenyl)-tetrahydro-3h-furo[3,4-c]furan-1-one
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(3s)-thian-3-yloxy]oxane-3,4,5-triol
C11H20O6S (280.09805400000005)